CVS, UnitedHealth press for FTC Chair Khan to be removed from PBM lawsuit

CVS, United Health Seek Removal Of FTC's Khan In PBM Case

Major pharmacy benefit manager owners are calling on a Federal Trade Commission administrative judge to disqualify three Democratic FTC commissioners from the agency's in-house lawsuit accusing them of artificially inflating insulin prices, arguing that the commissioners have repeatedly vilified PBMs and prejudged the proceeding.

CVS, UnitedHealth, Cigna ask FTC's Khan to disqualify herself from insulin case

CVS Health , UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.

CVS, UnitedHealth press for FTC Chair Khan to be removed from PBM lawsuit

UnitedHealth and CVS Caremark are seeking to disqualify a trio of FTC commissioners from a lawsuit against the country's largest PBMs due to being biased against the businesses.

CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit

In September, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts, and UnitedHealth Group Inc’s (NYSE:UNH) Optum—for allegedly engaging in unfair and anti-competitive practices that have inflated the list price of insulin medications. The complaint accuses the PBMs of creating a system that benefits them finan…

UnitedHealth, CVS, Cigna accuse FTC Chair Khan of 'serious bias' against PBMs

UnitedHealth Group and CVS Health are asking FTC commissioners to recuse themselves from a case against pharmacy benefit managers due to alleged bias.

CVS and UnitedHealth want FTC Chair Lina Khan to recuse herself from a case over insulin prices

CVS (CVS) and UnitedHealth Group (UNH) on Tuesday demanded that Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners recuse themselves from the agency’s lawsuit against the companies, accusing them of “blatant bias.”Read more...